
CAS 1313363-54-0: CGM097
Description:CGM097, with the CAS number 1313363-54-0, is a small molecule that has been investigated primarily for its potential therapeutic applications, particularly in the field of oncology. It functions as a selective inhibitor of certain protein kinases, which are crucial in regulating various cellular processes, including cell growth and division. The compound is characterized by its ability to interfere with specific signaling pathways that are often dysregulated in cancer cells, thereby inhibiting tumor proliferation. CGM097 has shown promise in preclinical studies, demonstrating efficacy against certain cancer types. Its chemical structure includes functional groups that contribute to its binding affinity and selectivity for target kinases. Additionally, the compound's pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are essential for determining its suitability for clinical use. Ongoing research aims to further elucidate its mechanism of action and potential side effects, as well as to optimize its formulation for therapeutic applications.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | NVP-CGM097 REF: TM-TQ0231CAS: 1313363-54-0 | 98.77% | 87.00 €~944.00 € | Mon 21 Apr 25 |
![]() | CGM-097 REF: 3D-NCC36354CAS: 1313363-54-0 | Min. 95% | To inquire | Fri 23 May 25 |

NVP-CGM097
Ref: TM-TQ0231
1mg | 87.00 € | ||
5mg | 207.00 € | ||
10mg | 341.00 € | ||
25mg | 520.00 € | ||
50mg | 682.00 € | ||
100mg | 944.00 € | ||
1mL*10mM (DMSO) | 300.00 € |

CGM-097
Ref: 3D-NCC36354
25mg | 1,229.00 € | ||
50mg | 1,709.00 € | ||
100mg | 2,664.00 € |